Combined silencing of VEGF-A and angiopoietin-2, a more effective way to inhibit the Ishikawa endometrial cancer cell line

BACKGROUND: Angiogenesis is critical for the growth and metastasis of solid tumors and is, therefore, an important therapeutic target. Despite the great research advances in tumor therapies targeting vascular endothelial growth factor (VEGF), drug resistance frequently occurs, and further strategies...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Onco Targets Ther
Hoofdauteurs: Xu, Xiaofeng, Yan, Yuhua, Xun, Qingying, Shi, Jiayu, Kong, Xiangyi, Wu, Jun, Zhou, Huaijun
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Dove Medical Press 2019
Onderwerpen:
Original Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6388957/
https://ncbi.nlm.nih.gov/pubmed/30863089
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S194064
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items